Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetylcysteine for Proteinuria in Non-Diabetic CKD
NCT00572663Phase 2Completed
- Sponsor
- Medical University of Gdańsk
- Start
- Jan 2005
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of acetylcysteine in chronic kidney disease (CKD) (2 arms), sponsored by Medical University of Gdańsk. Primary endpoint: Antiproteinuric effect. Started Jan 2005; status: completed.
02
Drugs
acetylcysteine
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00572663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00572663.